What is LBRX's price / book?

LBRX (LBRX) reported price / book of 1.9× in Q1 2026.

What does price / book mean?

Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

LBRX LBRX Price / book

Price / book at other companies

Bristol-Myers SquibbBMY

6.2×-1.0×

AlkermesALKS

3.4×-0.2×

MapLight Therapeutics, Inc. MPLT

2.2×—

Alto NeuroscienceANRO

3×+2.5×

Zevra Therapeutics, Inc.ZVRA

2.7×-7.2×

Opko HealthOPK

0.7×-0.1×

Other financials

Income statement

See full

Net income-$19.1M-259%

EPS (diluted)-$0.67+95.5%

Balance sheet

See full

Cash & equivalents$320.7M—

Total debt$3.5M—

Total equity$378.7M+481%

Total assets$393.5M—

Cash flow

See full

Operating cash flow-$23.3M-187%

CapEx$32.0K+52.4%

Free cash flow-$23.3M-186%

Valuation

See full

Market cap$874.06M+159%

Enterprise value$556.86M—

Returns & leverage

See full

Return on equity-27.9%—

Debt / equity0×—

Current ratio35.7×—

Where this comes from

Calculated from LBRX’s reported figures.

market cap/total stockholders equity=1.9×

Based on the most recent quarter.

The official record: LBRX’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about LBRX's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is LBRX's price / book?: LBRX (LBRX) reported price / book of 1.9× in Q1 2026.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.